Evidence map›Paper›PMID 38280624›Full record

ArticleHeart rhythm2024

Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.

Richard T Carrick, Hisham Ahamed, Eric Sung, Martin S Maron, Christopher Madias, Vennela Avula, Rachael Studley, Chen Bao, Nadia Bokhari, Erick Quintana and 4 more

Open access · greenAbstract read
In one paragraph

Article in Heart rhythm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Hypertrophic Cardiomyopathy: Current Perspectives.Reviews in cardiovascular medicine · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Richard T CarrickJohns Hopkins University School of Medicine, Heart and Vascular Institute, Baltimore, Maryland. Electronic address: rcarric5@jh.edu.
Hisham AhamedAmrita Institute of Medical Sciences and Research Centre, Amrita Hypertrophic Cardiomyopathy Center, Kochi, Kerala, India.
Eric SungJohns Hopkins University School of Medicine, Heart and Vascular Institute, Baltimore, Maryland.
Martin S MaronLahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, Massachusetts.
Christopher MadiasTufts Medical Center, Cardiac Arrhythmia Center, Boston, Massachusetts.
Vennela AvulaJohns Hopkins University School of Medicine, Heart and Vascular Institute, Baltimore, Maryland.
Rachael StudleyTufts Medical Center, Cardiac Arrhythmia Center, Boston, Massachusetts.
Chen BaoTufts Medical Center, Cardiac Arrhythmia Center, Boston, Massachusetts.
Nadia BokhariTufts Medical Center, Cardiac Arrhythmia Center, Boston, Massachusetts.
Erick QuintanaTufts Medical Center, Cardiac Arrhythmia Center, Boston, Massachusetts.
Ramiah Rajesh-KannanAmrita Institute of Medical Sciences and Research Centre, Amrita Hypertrophic Cardiomyopathy Center, Kochi, Kerala, India.
Barry J MaronLahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, Massachusetts.
Katherine C WuJohns Hopkins University School of Medicine, Heart and Vascular Institute, Baltimore, Maryland.
Ethan J RowinLahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, Massachusetts.
Tufts Medical Center · USJohns Hopkins University · USLahey Medical Center · USAmrita Institute of Medical Sciences and Research Centre · IN

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
NHLBI NIH HHS L30 HL165535NHLBI NIH HHS T32 HL007227
6 · The paper itself

Abstract

backgroundPatients with hypertrophic cardiomyopathy (HCM) are at risk of sudden death, and individuals with ≥1 major risk markers are considered for primary prevention implantable cardioverter-defibrillators. Guidelines recommend cardiac magnetic resonance (CMR) imaging to identify high-risk imaging features. However, CMR imaging is resource intensive and is not widely accessible worldwide.

objectiveThe purpose of this study was to develop electrocardiogram (ECG) deep-learning (DL) models for the identification of patients with HCM and high-risk imaging features.

methodsPatients with HCM evaluated at Tufts Medical Center (N = 1930; Boston, MA) were used to develop ECG-DL models for the prediction of high-risk imaging features: systolic dysfunction, massive hypertrophy (≥30 mm), apical aneurysm, and extensive late gadolinium enhancement. ECG-DL models were externally validated in a cohort of patients with HCM from the Amrita Hospital HCM Center (N = 233; Kochi, India).

resultsECG-DL models reliably identified high-risk features (systolic dysfunction, massive hypertrophy, apical aneurysm, and extensive late gadolinium enhancement) during holdout testing (c-statistic 0.72, 0.83, 0.93, and 0.76) and external validation (c-statistic 0.71, 0.76, 0.91, and 0.68). A hypothetical screening strategy using echocardiography combined with ECG-DL-guided selective CMR use demonstrated a sensitivity of 97% for identifying patients with high-risk features while reducing the number of recommended CMRs by 61%. The negative predictive value with this screening strategy for the absence of high-risk features in patients without ECG-DL recommendation for CMR was 99.5%.

conclusionIn HCM, novel ECG-DL models reliably identified patients with high-risk imaging features while offering the potential to reduce CMR testing requirements in underresourced areas.

Indexed as

Cardiomyopathy, HypertrophicDeep LearningElectrocardiographyMagnetic Resonance Imaging, CineDeath, Sudden, CardiacFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsCardiac magnetic resonance imagingDeep-learningElectrocardiographyHypertrophic cardiomyopathyRisk predictionSudden cardiac death

Identifiers

PMID38280624
PMCPMC11272903
OpenAlexW4391257097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.